K-V Pharmaceutical Co - FORM S-1/A - EX-12.1 - EXHIBIT 12.1 - August 24, 2011

Attached files

file filename
S-1/A - PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 - K-V Pharmaceutical Cods1a.htm
EX-99.3 - EXHIBIT 99.3 - K-V Pharmaceutical Codex993.htm
EX-99.4 - EXHIBIT 99.4 - K-V Pharmaceutical Codex994.htm
EX-23.3 - EXHIBIT 23.3 - K-V Pharmaceutical Codex233.htm
EX-99.5 - EXHIBIT 99.5 - K-V Pharmaceutical Codex995.htm
EX-99.1 - EXHIBIT 99.1 - K-V Pharmaceutical Codex991.htm
EX-25.1 - EXHIBIT 25.1 - K-V Pharmaceutical Codex251.htm
EX-99.2 - EXHIBIT 99.2 - K-V Pharmaceutical Codex992.htm
EX-23.2 - EXHIBIT 23.2 - K-V Pharmaceutical Codex232.htm

Exhibit 12.1

Statement re Computation of Ratio of Earnings to Fixed Charges

K-V Pharmaceutical Company

Computation of Ratio of Earnings to Fixed Charges

 

     Three Months
Ended		      Fiscal Year Ended  
     June 30, 2011      2011     2010     2009     2008     2007  

Determination of Earnings (Loss):

              

Income (loss) from continuing operations before taxes

    $ 25.4       $ (148.4 )    $ (309.5 )    $ (306.4 )    $ (72.8 )    $ (21.7 ) 

Fixed charges

      10.0         16.9        9.5        11.1        11.6        9.8   

Preferred dividend net of taxes

      —           (0.1 )      (0.1 )      (0.1 )      (0.1 )      (0.1 ) 

Total earnings (loss) as defined

    $ 35.4       $ (131.6 )    $ (300.1 )    $ (295.4 )    $ (61.3 )    $ (12.0 ) 

Determination of Fixed Charges:

              

Interest expense

    $ 8.8       $ 15.0      $ 8.0      $ 9.3      $ 9.2      $ 7.7   

Amortization of discounts and capitalized expenses related to debt

      1.0         0.4        —          —          1.3        1.3   

Estimate of interest within rental expense

      0.2         1.4        1.4        1.7        1.0        0.7   

Preferred dividend net of taxes

      —           0.1        0.1        0.1        0.1        0.1   

Total fixed charges

    $ 10.0       $ 16.9      $ 9.5      $ 11.1      $ 11.6      $ 9.8   

Ratio of Earnings to Fixed Charges (Deficiency)

      3.5         (7.8 )      (31.5 )      (26.7 )      (5.3 )      (1.2 ) 

Amount of deficiency to obtain one-to-one coverage

      N/A       $ 148.5      $ 309.6      $ 306.5      $ 72.9      $ 21.8   

K-V Pharmaceutical Co Reports